Antidiarrheals
Key Points
- Antidiarrheal agents reduce intestinal motility and secretion; primary agents activate opioid Mu-receptors in the GI tract.
- Contraindicated when infectious diarrhea is suspected (fever, bloody stool, high-grade pathogens) — slowing motility allows pathogen proliferation.
- Loperamide (Imodium) is first-line OTC antidiarrheal; does not cross the blood-brain barrier at therapeutic doses — minimal CNS effects.
- Diphenoxylate/atropine (Lomotil) is Schedule V; atropine is added to discourage abuse by causing anticholinergic discomfort at high doses.
- Octreotide is used for selected severe diarrhea pathways (for example refractory chemotherapy-related diarrhea) when standard antimotility agents are insufficient.
- Loperamide is contraindicated in children younger than 2 years and overdose can cause life-threatening dysrhythmia.
Pathophysiology
Diarrhea results from increased intestinal motility, reduced fluid/electrolyte absorption, or increased secretion into the intestinal lumen. Causes include viral/bacterial infection, inflammatory bowel disease, irritable bowel syndrome, and chemotherapy-related diarrhea (CRD).
Antidiarrheals work by:
- Binding opioid Mu-receptors in the intestinal wall → inhibit peristalsis → decrease motility → increased water/electrolyte absorption
- Prolonging intestinal transit time → firmer stool
Classification
| Type | Examples | Mechanism |
|---|---|---|
| Opioid-related | Loperamide (Imodium), diphenoxylate/atropine (Lomotil) | Opioid Mu-receptor agonism in GI tract → reduced motility |
| Adjuvant/Adsorbent | Bismuth subsalicylate (Pepto-Bismol), octreotide, pancreatin | Mucosal protection/anti-secretory effect, hormone-mediated intestinal secretion suppression, or enzyme replacement support |
| Anticholinergic | Hyoscyamine (Levsin) | Reduce GI spasm and secretion |
Nursing Assessment
NCLEX Focus
Before administering an antidiarrheal, assess for signs of infectious diarrhea (fever >101°F, bloody or mucus-containing stool, severe abdominal pain) — antidiarrheals are contraindicated in these cases.
- Assess stool characteristics: frequency, consistency, color (bloody or mucus-containing = infection concern).
- Assess vital signs and hydration status: skin turgor, mucous membranes, daily weights, urine output.
- Assess for fever — withhold antidiarrheal if fever is present and notify provider.
- Assess for blood or mucus in stool and severe abdominal pain; hold antimotility therapy and escalate for infectious or inflammatory etiologies.
- Assess for diarrhea cause: travel history, recent antibiotics (C. difficile risk), chemotherapy.
- Assess for abdominal pain, bowel sounds, and distention.
- Before anticholinergic use (e.g., hyoscyamine), screen for glaucoma, myasthenia gravis, paralytic ileus, and possible bowel-obstruction pattern.
Nursing Interventions
- Monitor I&O and daily weights; replace fluids and electrolytes as ordered — diarrhea causes dehydration and electrolyte imbalance.
- Educate patients to avoid caffeine (increases GI motility) during diarrhea episodes.
- Caution patients against driving or operating machinery — drowsiness/dizziness possible with opioid-based agents.
- Do not use diphenoxylate/atropine in patients with liver disease — impaired metabolism increases systemic opioid effects.
- Instruct clients taking loperamide or diphenoxylate-based therapy to avoid alcohol and other CNS depressants.
- Reassess diphenoxylate-atropine effectiveness early; if symptoms are not controlled within about 10 days, notify provider because further use is unlikely to help.
- Monitor for high-dose diphenoxylate-atropine toxicity (opioid and anticholinergic effects), including hyperthermia, flushing, tachycardia, lethargy, hallucinations, and respiratory depression.
- For octreotide diarrhea pathways, verify ordered formulation/route because oral octreotide capsules are not used to treat diarrhea.
- For pancreatin, administer with meals/snacks and a full glass of water; swallow whole (do not crush/chew) to reduce oral-mucosal irritation and preserve effect.
Infectious Diarrhea Contraindication
Antidiarrheal drugs should NOT be used when infection is suspected (fever, bloody stool, positive cultures). Slowing motility in infectious diarrhea traps pathogens, worsens illness, and may cause toxic megacolon in C. difficile infection.
Loperamide Safety
Do not use in children younger than 2 years. Exceeding labeled doses can cause serious ventricular dysrhythmias and death; review interacting drugs (especially antiarrhythmics and selected antipsychotics) before administration.
Diphenoxylate-Atropine Safety
Avoid use in pediatric clients younger than 6 years and in contraindicated severe infectious diarrhea patterns. Watch for atropinism and opioid toxicity at excessive doses.
Dehydration Assessment
Diarrhea rapidly depletes fluid and electrolytes (sodium, potassium, bicarbonate). Assess for dehydration signs and institute oral rehydration therapy early; IV fluids may be required for severe dehydration.
Pharmacology
| Drug | Schedule | Key Nursing Considerations |
|---|---|---|
| Loperamide (Imodium) | OTC | Does not cross BBB; no CNS effects at therapeutic doses; do not exceed 8 mg/day (OTC limit) |
| Diphenoxylate/atropine (Lomotil) | Schedule V | Atropine added to discourage abuse; anticholinergic side effects at high doses; avoid in liver disease |
| Bismuth subsalicylate (Pepto-Bismol) | OTC | Blackens stool/tongue (inform patient); avoid with salicylate allergy or concurrent salicylates; avoid in children/teens with flu-like illness (Reye risk); avoid with ulcer/bleeding history or bloody-black stool |
| Octreotide (Sandostatin) | Rx | Consider for severe chemotherapy-related diarrhea not controlled with loperamide; SC/IV or depot IM pathways are used for diarrhea indications |
| Pancreatin/Pancrelipase (Creon) | Rx/OTC by product | Enzyme-replacement adjunct for pancreatic insufficiency-related diarrhea; give with food and swallow whole |
| Hyoscyamine | Rx | Anticholinergic antimotility effect; contraindicated in glaucoma, myasthenia gravis, and paralytic ileus; avoid when obstruction is possible |
| Lactobacillus probiotics | OTC/Rx by product | Adjunct prevention/treatment support in selected diarrhea patterns; pediatric dosing is product- and age-based; mild gas/bloating common |
Clinical Judgment Application
Clinical Scenario
A patient on broad-spectrum antibiotics develops 6 loose stools/day without fever or blood in stool. Loperamide 2 mg after each loose stool is ordered (max 16 mg/day).
- Recognize Cues: Antibiotic-associated diarrhea; absence of fever or bloody stool.
- Analyze Cues: Rule out C. difficile before treating; stool culture may be indicated.
- Prioritize Hypotheses: Fluid/electrolyte replacement first; assess infection status.
- Generate Solutions: Administer per order while monitoring for C. diff symptoms (fever, abdominal cramping, bloody/watery stool).
- Take Action: Administer loperamide; monitor I&O; encourage clear fluids and electrolyte solutions.
- Evaluate Outcomes: Stool frequency decreases; hydration maintained; no signs of C. difficile.
Related Concepts
- diarrhea-assessment-and-management - Comprehensive clinical assessment and nursing management.
- clostridioides-difficile-infection - Major cause of antibiotic-associated diarrhea where antidiarrheals are contraindicated.
- inflammatory-bowel-disease - Chronic disease context where antidiarrheals are used cautiously.
- fluid-volume-deficit-hypovolemia-and-dehydration - Key complication of diarrhea to prevent and treat.
- laxatives - Opposing drug class for constipation management.
Self-Check
- What findings would make antidiarrheals contraindicated in a patient with diarrhea?
- How does loperamide differ from diphenoxylate/atropine in terms of CNS effects?
- Why is bismuth subsalicylate (Pepto-Bismol) avoided in children with viral illnesses?